AI assistant
Sanofi India Ltd — Capital/Financing Update 2020
May 29, 2020
59270_rns_2020-05-29_b3d87c48-ffa5-4a1d-be24-4a4075d02c6e.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [89 x 71] intentionally omitted <==
29[th] May 2020
The Secretary The Secretary Bombay Stock Exchange Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Floor Dalal Street Plot No. C/1, G Block Mumbai 400 001 Bandra-Kurla Complex Bandra East Mumbai 400 050
Closing of transaction relating to slump Sale and transfer of the manufacturing facility of the Company at Ankleshwar, Gujarat
Dear Sirs
This has reference to our letter dated 11[th] September 2019 wherein we intimated you that the Board of Directors of Sanofi India Limited (the Company) at its meeting held on 10[th] September 2019, approved a transaction for the slump sale and transfer of the manufacturing facility at Ankleshwar, Gujarat to Zentiva Private Limited, for a consideration of Rs. 2,617 million, subject to customary working capital adjustments. The closing of this transaction was subject to certain conditions precedent as described in the Business Transfer Agreement. It was anticipated then that the closing of this transaction will be achieved on or before 31[st] March 2020.
We also intimated you vide our letter dated 27[th] March 2020 that due to delay in receiving regulatory approvals, the closing of this transaction has been postponed and is expected to be achieved during the quarter ending 30[th] June 2020.
We would like to inform you that after completion of conditions precedent as per Business Transfer Agreement, the transaction has been closed on 29[th] May 2020.
After the initial working capital adjustment on the closing date, the total consideration for the transaction has been calculated at Rs. 3,206.8 million. The Company has received the initial consideration of Rs. 2,933.4 million on the closing date. This is subject to a customary post-closing working capital adjustment in accordance with the terms of the Business Transfer Agreement, and the balance consideration of Rs. 273.4 million will be received within 10 business days of full transfer of products as specified in the Business Transfer Agreement. It is anticipated that the full transfer of products will be completed by September 2021.
This is for your information and records.
Thanking you,
Yours faithfully For SANOFI INDIA LIMITED
GIRISH ARJAN Digitally signed by GIRISH ARJAN TEKCHANDANI TEKCHANDANI Date: 2020.05.29 16:24:30 +05'30'
GIRISH TEKCHANDANI COMPANY SECRETARY
==> picture [472 x 13] intentionally omitted <==